Acute Myeloid Leukemia Clinical Trial

A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists

Summary

This is a pilot study to evaluate the usability and feasibility of a patient-centered communication tool (University of Rochester-Geriatric Oncology Assessment for acute myeloid Leukemia or UR-GOAL) among 15 older patients with AML, their caregivers, and oncologists.

View Full Description

Full Description

Older adults with AML and their caregivers may benefit from help and support in understanding their treatment options. This pilot study seeks to evaluate the usability and feasibility of the UR-GOAL communication tool. The UR-GOAL tool will incorporate conjoint analysis to elicit patient preferences as well as assessments of fitness and prognostic awareness.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria for Patients:

Age ≥60 years (conventional definition of older age in AML)
Newly diagnosed AML
Considering treatment
Able to provide informed consent
English-speaking

Inclusion Criteria for Caregivers:

Selected by the patient when asked if there is a "family member, partner, friend or caregiver [age 21 or older] with whom you discuss or who can be helpful in health-related matters;" patients who cannot identify such a person ("caregiver") can be eligible for the study. A caregiver need not be someone who lives with the patient or provides direct hands-on care. A caregiver can be any person who provides support (in any way) to the patient.
Able to provide informed consent
English-speaking

Inclusion Criteria for Oncologists:

A practicing oncologist
At least one of their patients are recruited to the study
English-speaking

Exclusion Criteria: None

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

15

Study ID:

NCT04625413

Recruitment Status:

Completed

Sponsor:

University of Rochester

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Rochester Medical Center
Rochester New York, 14623, United States

How clear is this clinincal trial information?

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

15

Study ID:

NCT04625413

Recruitment Status:

Completed

Sponsor:


University of Rochester

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.